TCT recap: TRYTON, EuroMax, CoreValve, TAVR with CoreValve

Kim Carollo | | Cardiovascular Business | Interventional Cardiology

In case you missed it, here is our previous coverage from TCT.

In the EUROMAX trial, researchers found that compared to heparin, giving bivalirudin to STEMI patients lowers the risk of death and complications from bleeding, but the strategy faces barriers in the U.S.

The TRYTON trial did meet expectations based on its primary clinical endpoint. The investigators found that using the Tryton stent in patients with large bifurcated coronary lesions led to a higher rate of target vessel failure when compared to patients treated with standard practice and argued that there could be several reasons why the trial was unsuccessful.

In an analysis of the CoreValve device, clinical functionality and quality of life improved in patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR). A trial of the CoreValve device found it to be safe and effective in TAVR.

Kim Carollo,

Contributor

Related Content

Surgery outperforms PCI in NSTEMI patients with multivessel CAD
Boston Scientific enters IVL arms race with acquisition worth up to $664M
FDA sees value in no-implant heart failure device
Radial secondary access during TAVR limits complications
Medtronic’s Harmony TPVR system gains CE mark approval
History made: Young child treated with new heart device for very first time

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.